Nisa Investment Advisors, LLC Pyxis Oncology, Inc. Transaction History
Nisa Investment Advisors, LLC
- $25.4 Billion
- Q3 2025
A detailed history of Nisa Investment Advisors, LLC transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 961 shares of PYXS stock, worth $4,334. This represents 0.0% of its overall portfolio holdings.
Number of Shares
961
Previous 961
-0.0%
Holding current value
$4,334
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding PYXS
# of Institutions
72Shares Held
23.3MCall Options Held
21.5KPut Options Held
0-
Laurion Capital Management LP New York, NY3.63MShares$16.4 Million0.15% of portfolio
-
Black Rock Inc. New York, NY2.79MShares$12.6 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.5MShares$11.3 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.16MShares$9.76 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY1.18MShares$5.31 Million0.01% of portfolio
About Pyxis Oncology, Inc.
- Ticker PYXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,096,400
- Market Cap $158M
- Description
- Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...